CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
StemBANCC focuses on creating a biorepository and drug discovery pipeline using human induced pluripotent stem cells to address neurodegeneration, neurodysfunction, and diabetes. The project emphasizes developing disease models and high-throughput assays based on well-characterized clinical data and genetic information…
StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug discovery pipeline based upon human induced pluripotent stem cells (hiPSC).
This unrivalled opportunity will address the pressing therapeutic need in neurodegeneration, neurodysfunction and diabetes.
We have immediate access to richly phenotyped subjects with a wealth of clinical data.
Furthermore our cohorts include genetic and genome data, allowing us to caref…
F. HOFFMANN-LA ROCHE AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Oxford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CONCENTRIS RESEARCH MANAGEMENT GMBH
Germany, Furstenfeldbruck
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
